
Precigen Inc
NASDAQ:PGEN

Intrinsic Value
The intrinsic value of one
PGEN
stock under the Base Case scenario is
6.61
USD.
Compared to the current market price of 1.37 USD,
Precigen Inc
is
Undervalued by 79%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Precigen Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Precigen Inc
Balance Sheet Decomposition
Precigen Inc
Current Assets | 102.4m |
Cash & Short-Term Investments | 97.9m |
Receivables | 1.2m |
Other Current Assets | 3.3m |
Non-Current Assets | 42.9m |
PP&E | 18.9m |
Intangibles | 23.6m |
Other Non-Current Assets | 371k |
Free Cash Flow Analysis
Precigen Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Precigen Inc
Revenue
|
3.9m
USD
|
Cost of Revenue
|
-4.3m
USD
|
Gross Profit
|
-342k
USD
|
Operating Expenses
|
-94.4m
USD
|
Operating Income
|
-94.7m
USD
|
Other Expenses
|
-31.5m
USD
|
Net Income
|
-126.2m
USD
|
PGEN Profitability Score
Profitability Due Diligence
Precigen Inc's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

Score
Precigen Inc's profitability score is 14/100. The higher the profitability score, the more profitable the company is.
PGEN Solvency Score
Solvency Due Diligence
Precigen Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Score
Precigen Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PGEN Price Targets Summary
Precigen Inc
According to Wall Street analysts, the average 1-year price target for
PGEN
is 6.12 USD
with a low forecast of 6.06 USD and a high forecast of 6.3 USD.
Dividends
Current shareholder yield for PGEN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PGEN
stock under the Base Case scenario is
6.61
USD.
Compared to the current market price of 1.37 USD,
Precigen Inc
is
Undervalued by 79%.